Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020)
Armata Pharmaceuticals (ARMP) posted FCF Margin of 13319.35% for Q2 2020, down 11.6% sequentially from 11935.0% in Q4 2017.
Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020) Analysis & Trends
Armata Pharmaceuticals has reported FCF Margin for 6 years, with the latest figure at 13319.35% in Q2 2020.
- Quarterly FCF Margin changed N/A year-over-year to 13319.35% in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 13433.33% (changed N/A YoY) and the FY2017 annual result came in at 8043.48%, down 385694.0% from the prior year.
- FCF Margin slipped to 13319.35% in Q2 2020 per ARMP's latest filing, from 11935.0% in the prior quarter.
- Over five years, FCF Margin peaked at 1647.37% in Q3 2017 and troughed at 13319.35% in Q2 2020.
- A 3-year average of 8053.3% and a median of 10475.0% in 2017 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2016 and 2017: FCF Margin tumbled 906928 bps in 2016, then jumped 924918 bps in 2017.
- Over 3 years, FCF Margin stood at 6868.18% in 2016, then slumped by 74 bps to 11935.0% in 2017, then decreased by 12 bps to 13319.35% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 13319.35%, 11935.0%, and 1647.37% for Q2 2020, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -13,319.35% |
| Dec 31, 2017 | -11,935.00% |
| Sep 30, 2017 | -1,647.37% |
| Jun 30, 2017 | -10,475.00% |
| Mar 31, 2017 | -11,393.10% |
| Dec 31, 2016 | -6,868.18% |
| Sep 30, 2016 | -10,896.55% |
| Jun 30, 2016 | -2,929.13% |
| Mar 31, 2016 | -3,016.04% |
| Dec 31, 2015 | -1,849.22% |
| Sep 30, 2015 | -1,827.27% |
| Jun 30, 2015 | -2,618.63% |
| Mar 31, 2015 | -2,294.12% |
| Dec 31, 2014 | -3,173.27% |
| Sep 30, 2014 | -2,683.50% |
| Jun 30, 2014 | -3,846.53% |
| Mar 31, 2014 | -3,769.23% |
| Dec 31, 2013 | 562.30% |
| Sep 30, 2013 | -84,200.00% |
| Jun 30, 2013 | -424.20% |